L&C BIO Co.,LTD

KOSDAQ-290650
KOSDAQ
Healthcare Medical - Specialties
Global Rank
#13561
Country Rank
#324
Market Cap
569.43 M
Price
23.13
Change (%)
0.16%
Volume
211,479

L&C BIO Co.,LTD's latest marketcap:

569.43 M

As of 08/13/2025, L&C BIO Co.,LTD's market capitalization has reached $569.43 M. According to our data, L&C BIO Co.,LTD is the 13561th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 569.43 M
Revenue (ttm) 52.99 M
Net Income (ttm) 100.53 M
Shares Out 24.62 M
EPS (ttm) 4.02
Forward PE 0.00
Ex-Dividend Date 12/27/2024
Earnings Date 08/12/2025
Market Cap Chart
Data Updated: 08/13/2025

L&C BIO Co.,LTD's yearly market capitalization.

L&C BIO Co.,LTD has seen its market value grow from ₩142.15 B to ₩787.8 B since 2018, representing a total increase of 454.19% and an annual compound growth rate (CAGR) of 29.49%.
Date Market Cap(₩) Market Cap(USD) Change (%) Global Rank
08/13/2025 ₩787.8 B $569.43 M 52.88% 13561
12/30/2024 ₩546.71 B $366.29 M -16.9% 15066
12/28/2023 ₩657.86 B $506.55 M 25.54% 12890
12/29/2022 ₩524.02 B $413.98 M -36.89% 13476
12/30/2021 ₩830.27 B $697.42 M 10% 11331
12/30/2020 ₩754.76 B $694.38 M 300.62% 9813
12/30/2019 ₩188.4 B $162.02 M 32.53% 15723
12/28/2018 ₩142.15 B $126.52 M 16093

Company Profile

About L&C Bio Co., Ltd

L&C Bio Co., Ltd is a pioneering research and development company specializing in tissue regeneration medicine. The company is dedicated to advancing medical and cosmetic solutions through innovative biotechnology.

Key Offerings

  • Human Tissue Products: Cutting-edge solutions for tissue repair and regeneration.
  • Medical Devices: Advanced tools and technologies for healthcare applications.
  • Cosmetics: Scientifically backed skincare and beauty products.

Company Background

Founded in 2011, L&C Bio Co., Ltd is headquartered in Seongnam-si, South Korea. The company continues to drive innovation in regenerative medicine and related fields.

Frequently Asked Questions

  • What is L&C BIO Co.,LTD's (KOSDAQ-290650) current market cap?
    As of 08/13/2025, L&C BIO Co.,LTD (including the parent company, if applicable) has an estimated market capitalization of $569.43 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • L&C BIO Co.,LTD global market capitalization ranking is approximately 13561 as of 08/13/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.